Artemis Medicare Services Limited

Artemis Medicare Services Limited (ARTEMISMED) is a micro-cap Healthcare company valued at ₹4,852 crore operating in Hospital on the NSE and BSE.

Recent price move

Artemis Medicare Services Limited last traded at ₹306.2, modestly up 1.06% on the day.

Recent developments

On 2026-07-10, the company announced a dividend of ₹0.45 per share, ex-date. Promoter holding remained at 58.39% as of 2026-06-30, while foreign institutional holding increased by 0.10 points and domestic institutional holding decreased by 0.49 points in the quarter.

Financial performance

The company's business is improving, with annual revenue rising 18.4% and net profit growing 25.0% year-over-year. The latest quarter saw revenue increase 14.9% and net profit jump 49.7% compared to the same quarter a year earlier, with net profit margin expanding 0.5 percentage points to 9.6%.

Valuation multiples

The stock trades at 46.7 times earnings, a premium to the Healthcare median of 32.0, 5.70 times book value. It yields 0.1%.

Things to watch

The stock is 11.2% below its 52-week high. Domestic institutional holding fell by 0.49 points in the quarter, and the company's return on equity is 11.1%, which is lower than its return on capital employed of 13.9%.

Where it stands

The company has shown strong growth in both revenue and net profit over the past five years, with profit growing at 71.5% annually. The latest quarter's net profit rose sharply, but the stock remains below its 52-week high. The most significant figure is the 11.2% drop from the 52-week high.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.